The maximal proteolytic activity in plasma that can be obtained by activation with urokinase and in the presence of natural inhibitors is designated proteolytic capacity. A modified caseinolytic method measuring this parameter has been described. In a normal population large variations between individuals were found, and this is probably due to differences in the plasminogen-plasmin level. The caseinolytic method correlated well with in vitro thrombolysis and with fibrinogenolysis in plasma. Serum had a higher proteolytic capacity than plasma. Pregnancy and the oral contraceptives caused a pronounced rise in proteolytic capacity, whereas thyrotoxicosis caused a decrease in the capacity. Two healthy donors, one with zero proteolytic capacity and a plasminogen level of 35–45%, and one with very high proteolytic capacity and a plasminogen level of about 130% were studied in particular. No increased tendency for thrombosis was found in persons with very low or zero proteolytic capacity.
No takes yet. Share an insight, caveat, or question.
Carl Ditlef Jacobsen (1968) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: